Dr Martens chief executive Ije Nwokorie has bought more than £85,000 worth of shares in the footwear brand following its recent profit uplift.

A London Stock Exchange filing showed Nwokorie purchased 112,500 ordinary shares last Friday at 76.1p each, taking the total value of the transaction to around £85,600.

The purchase was disclosed yesterday, 16 June.

A separate filing also showed that Nwokorie and chief financial officer Giles Wilson had increased their holdings through Dr Martens’ HMRC-approved Share Incentive Plan.

Both executives bought 202 partnership shares at 74.37p per share on 11 June and received a matching allocation of 202 free shares.

The all-employee scheme allows staff to buy shares from salary, with Dr Martens providing matching shares.

The move signals confidence from the bootmaker’s leadership after the business reported a 61 per cent rise in adjusted pre-tax profit for the year to 29 March 2026.

Dr Martens said its 2025 financial year had focused on stabilising the business, while the current year has centred on shifting towards a more consumer-first model.

The company has reduced clearance activity across both its direct-to-consumer and wholesale operations, restructured leadership teams and simplified its operating model to improve accountability.

Its next financial year will mark the start of the “scale” phase of its Levers for Growth strategy, which is built around three stages. These are stabilise, pivot and scale.

Nwokorie’s appointment as chief executive was first announced in April 2024.

Before joining Dr Martens, he spent more than six years in a senior director role at Apple.

Click here to sign up to Retail Gazette‘s free daily email newsletter